PMFA
TEVA icon

Plante Moran Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Plante Moran Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66K Buy
+49
New +$1.63K ﹤0.01% 779
2020
Q1 		– Sell
-137
Closed -$1K – 836
2019
Q4 		$1K Hold
137
– – ﹤0.01% 730
2019
Q3 		$1K Hold
137
– – ﹤0.01% 825
2019
Q2 		$1K Hold
137
– – ﹤0.01% 765
2019
Q1 		$2K Hold
137
– – ﹤0.01% 725
2018
Q4 		$2K Hold
137
– – ﹤0.01% 750
2018
Q3 		$3K Hold
137
– – ﹤0.01% 658
2018
Q2 		$3K Sell
137
-85
-38% -$1.73K ﹤0.01% 690
2018
Q1 		$4K Buy
222
+85
+62% +$1.66K ﹤0.01% 763
2017
Q4 		$3K Hold
137
– – ﹤0.01% 767
2017
Q3 		$2K Hold
137
– – ﹤0.01% 736
2017
Q2 		$5K Hold
137
– – ﹤0.01% 670
2017
Q1 		$4K Sell
137
-720
-84% -$24.6K ﹤0.01% 736
2016
Q4 		$31K Buy
857
+137
+19% +$5.47K 0.02% 409
2016
Q3 		$33K Sell
720
-72
-9% -$3.76K 0.02% 396
2016
Q2 		$40K Buy
792
+677
+589% +$36K 0.03% 326
2016
Q1 		$6K Buy
+115
New +$6.75K ﹤0.01% 565
2014
Q3 		– Sell
-250
Closed -$13K – 849
2014
Q2 		$13K Hold
250
– – 0.01% 463
2014
Q1 		$13K Sell
250
-83
-25% -$3.84K 0.01% 314
2013
Q4 		$13K Buy
333
+83
+33% +$3.27K 0.01% 410
2013
Q3 		$9K Hold
250
– – 0.01% 404
2013
Q2 		$10K Buy
+250
New +$9.74K 0.01% 352

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Plante Moran Financial Advisors's TEVA Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 49 shares worth $1.66K. The stake represents ﹤0.01% of the portfolio and ranks #779 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in TEVA as recently as Q4 2019.

Plante Moran Financial Advisors first reported a position in TEVA in Q2 2013 and has held it in 22 quarters since. The position peaked at $40K in Q2 2016. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Plante Moran Financial Advisors held 49 shares of Teva Pharmaceuticals worth $1.66K as of Q2 2026.
  • Teva Pharmaceuticals was a new Plante Moran Financial Advisors position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #779 holding.
  • Plante Moran Financial Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 22 quarters since.
  • Plante Moran Financial Advisors's Teva Pharmaceuticals position peaked at $40K in Q2 2016.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.